Skip to main content
. 2004 Oct 30;23(11):1335–1342. doi: 10.1016/j.vaccine.2004.09.015

Fig. 5.

Fig. 5

Inhibition of viral plaque formation by (A) intestine lavages and (B) sera prepared from mice fed recombinant LcS. Maximum reduction in number of plaques, expressed as a percentage of plaques obtained for the negative control samples, using (A) intestinal lavages or (B) sera collected from mice fed with rTGEV-S-expressing LcS was 13.35 ± 0.77% and 15.70 ± 0.77%, respectively. Results are mean values and standard errors of triplicates.